Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can Omega-3s and a prostate drug keep Low-Risk cancer in check?

NCT ID NCT01653925

Prevention Sponsor: CHU de Quebec-Universite Laval Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether eating more omega-3 fatty acids (like those in fish oil) and taking a drug called dutasteride can slow the growth of low-risk prostate cancer. The 120 participants are men on active surveillance, meaning their cancer is being watched rather than treated right away. Researchers will check how these interventions affect fat levels and gene activity in the blood and prostate tissue.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dutasteride and omega-3 fatty acids
What this could lead to
If it works, this could point toward a way to prevent low-risk prostate cancer from progressing, potentially reducing the need for more aggressive treatments.
What could go wrong
This is an early-stage study with only 120 participants, so results may not apply to everyone. The dietary changes and drug may have side effects or show no clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Oct 2010

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 75 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Low-risk prostatic neoplasms * Candidate for active surveillance * Informed consent Exclusion Criteria: * Current fish oil supplementation * Current NSAID use

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low grade prostate cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

prostate cancer prostate neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low grade prostate cancer Prostatic neoplasms

Contacts and locations

Locations

  • Hotel-Dieu of Quebec

    Québec, Quebec, G1R 2J6, Canada

  • Institute of nutraceuticals and functional food of Laval University

    Québec, Quebec, G1V 0A6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.